Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Toronto
Clinical trial register · Canada

Clinical Trials in Toronto, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3491
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Toronto 8 Montreal 8 Vancouver 6 Québec 6 London 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Toronto

8 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Oshawa, Toronto, Québec
2026-04-23
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
NCT07090499Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 1
540
Toronto, Montreal
2025-08-20
Recruiting
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
NCT05037279Bladder Cancer, Bladder Cancer Recurrent, Neoplasm Recurrence, Urothelial Carcinoma Bladder
Verity Pharmaceuticals Inc.
Phase 3
540
Vancouver, Kingston, Toronto, Montreal
2024-04-24
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Vancouver, Toronto, Montreal, Québec, Sherbrooke
2024-03-28
Active, closed
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
NCT06111235Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma
CG Oncology, Inc.
Phase 3
367
Vancouver, Halifax, London, Toronto, Montreal
2023-12-14
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Halifax, Hamilton, Toronto, Montreal, Québec, Saint Jerome Quebec
2023-03-23
Recruiting
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)
NCT04574960Bladder Cancer, Bladder Urothelial Carcinoma
University Health Network, Toronto
Phase 3
14
Ottawa, Toronto
2021-02-08
Active, closed
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
184
Brampton, Hamilton, Newmarket, Ottawa, Toronto, Montreal, Québec
2018-12-21
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-canada/city/toronto

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 13 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Toronto that also match the filters currently applied.

How many clinical trials are recruiting in Toronto?

4 of the 8 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Toronto), 8 studies
PhaseStudiesRecruitingShare
Phase 35362.5%
Phase 11112.5%
Phase 1/21012.5%
Phase 21012.5%

Most active sponsors

Lead sponsors with the most studies (Toronto)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC21
CG Oncology, Inc.10
ImmunoVaccine Technologies, Inc. (IMV Inc.)10
Janssen Research & Development, LLC10
Pfizer11
University Health Network, Toronto11
Verity Pharmaceuticals Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.